CA3219287C - Nouveau plasmide auxiliaire double - Google Patents

Nouveau plasmide auxiliaire double

Info

Publication number
CA3219287C
CA3219287C CA3219287A CA3219287A CA3219287C CA 3219287 C CA3219287 C CA 3219287C CA 3219287 A CA3219287 A CA 3219287A CA 3219287 A CA3219287 A CA 3219287A CA 3219287 C CA3219287 C CA 3219287C
Authority
CA
Canada
Prior art keywords
gene
plasmid
rep
aspects
aav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3219287A
Other languages
English (en)
Other versions
CA3219287A1 (fr
Inventor
Joo Seok HAN
Hoon Young KONG
Yoon Hyung HWANG
Original Assignee
Elisigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elisigen Inc filed Critical Elisigen Inc
Priority claimed from PCT/KR2022/007553 external-priority patent/WO2022250491A1/fr
Publication of CA3219287A1 publication Critical patent/CA3219287A1/fr
Application granted granted Critical
Publication of CA3219287C publication Critical patent/CA3219287C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne un plasmide auxiliaire double pour produire un virus adéno-associé recombiné. Le procédé de transfection double utilisant le plasmide auxiliaire double de la présente invention est avantageux comparé au procédé de transfection triple généralement utilisé pour la production de virus adéno-associé car il présente les avantages suivants : 1) augmentation des chances de cotransfection ; 2) augmentation de la productivité du virus adéno-associé recombiné ; 3) réduction du coût et du temps de production et de purification du plasmide, etc. et peut donc être utilisé utilement pour la production efficace d'un agent de thérapie génique.
CA3219287A 2021-05-27 2022-05-27 Nouveau plasmide auxiliaire double Active CA3219287C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20210068364 2021-05-27
KR10-2021-0068364 2021-05-27
PCT/KR2022/007553 WO2022250491A1 (fr) 2021-05-27 2022-05-27 Nouveau plasmide auxiliaire double

Publications (2)

Publication Number Publication Date
CA3219287A1 CA3219287A1 (fr) 2022-12-01
CA3219287C true CA3219287C (fr) 2026-02-24

Family

ID=

Similar Documents

Publication Publication Date Title
US20260092291A1 (en) Novel dual helper plasmid
CA3249551A1 (fr) Variants de capside d'aav et leurs utilisations
JP2025069281A (ja) 調節可能な発現系
US20250163455A1 (en) Intron fragments
KR20250131772A (ko) 전두측두엽 치매에 대한 유전자 요법
US20250188128A1 (en) Adeno-associated virus compositions having increased heart enrichment
CN116096904A (zh) 改进的aav-abcd1构建体和用于治疗或预防肾上腺脑白质营养不良(ald)和/或肾上腺脊髓神经病(amn)的用途
CN118813559A (zh) shRNA表达框、携带其的多核苷酸序列及其应用
CA3130221A1 (fr) Compositions et methodes de traitement de la dystrophie musculaire oculopharyngee (opmd)
CA3219287C (fr) Nouveau plasmide auxiliaire double
US12305188B2 (en) Dual helper plasmid
JP2025534169A (ja) ｓｎＲＮＡ核酸分子およびその使用
US20240024514A1 (en) Recombinant adeno-associated viruses with enhanced liver tropism and uses thereof
US20260125704A1 (en) rAAV capsids
EP4534097A1 (fr) Composition pour le traitement de maladies rétiniennes ou maculaires
EA049452B1 (ru) Новые интронные фрагменты
WO2025212933A1 (fr) Méthodes et compositions destinées à réduire l'expression de tau
WO2025235666A1 (fr) Peptides ciblant alpl ldlr traverser la barrière hémato-encéphalique
WO2025128817A1 (fr) Micro-arn artificiels ciblant tau
HK40121156A (en) Composition for treating retinal or macular diseases
BR122025008690A2 (pt) Polinucleotídeo, vetor, célula in vitro, método para produzir uma partícula de virus recombinante, partícula de virus recombinante e uso
BR112022024345B1 (pt) Polinucleotídeo isolado, vetor, célula procariótica in vitro, método para produzir uma partícula de virus recombinante, partícula de virus recombinante adenoassociado e uso